Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06282172 · ClinicalTrials.gov registry record · NA
Histological Evaluation of BTL-785F Device's Effect on Submental Subcutaneous Adipose Tissue
A NA study of Fat Burn, sponsored by BTL Industries.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT06282172: Completed NA study of Fat Burn, sponsored by BTL Industries.
NCT06282172 is a NA study of Fat Burn that has completed, run by BTL Industries. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06282172, a NA study of Fat Burn, has completed, sponsored by BTL Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate the safety and effectiveness of the BTL-785F system equipped with the BTL-785-7 applicator for non-invasive reduction of subcutaneous submental fat.
Primary Outcome
Histological evaluation of changes in the shape and size of submental adipose cells, based on biopsies obtained from both the treatment and control groups.
Conditions Studied
Interventions
- DEVICE Treatment with BTL-785-7
Study Locations (1)
New Jersey
- Schweiger Dermatology PC, Research Division - Hackensack
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2023-07-25 |
| Est. Completion | 2023-12-18 |
| Phase | NA |
What the finished NCT06282172 record still lists
NCT06282172 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Fat Burn appearing as the primary indexed condition, and to 1 intervention - of which Treatment with BTL-785-7 is the first listed.
NCT06282172 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06282172 about?
NCT06282172 is a clinical study titled "Histological Evaluation of BTL-785F Device's Effect on Submental Subcutaneous Adipose Tissue". This study aims to evaluate the safety and effectiveness of the BTL-785F system equipped with the BTL-785-7 applicator for non-invasive reduction of subcutaneous submental fat.
What is the current status of trial NCT06282172?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2023-07-25. Estimated completion is 2023-12-18.
What conditions does trial NCT06282172 study?
This clinical trial studies the following conditions: Fat Burn.
What interventions are being tested in trial NCT06282172?
The interventions under investigation include: Treatment with BTL-785-7 (DEVICE).
Who is sponsoring clinical trial NCT06282172?
This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06282172 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fat Burn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06282172's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI